Anesiva 'Pain-free' High Growth

Anesiva (ANSV) is a tiny biopharmaceutical company about to enter a stage of high growth thanks to the successful launch of a niche pain relief product that has the potential for adoption as the standard treatment for pain related to needle procedures and orthopedic surgeries.

It All Starts With Zingo: Zingo is a needle free, painless, topical product approved by the FDA for use on children ages 3 to 18 in order to numb the skin prior to drawing blood or inserting an IV. Each Zingo device contains .5 mg sterile lidocaine powder. When the device is activated, compressed gas accelerates the lidocaine particles into the skin, numbing the area after approximately one minute. This is a vast improvement over anesthetic creams which can take between 30 to 60 minutes to work.